Transferrin receptor binding valency determines the circulating half-life and weight-loss efficacy of Fc-FGF21 in TfR-humanized mice
Hong Zhou, Yanru Deng, Huiqiao Li, Jieyi Meng, Leon Gabriel Straub, Shangang Zhao, Yi Zhu
This study shows that Fc-FGF21's weight-loss efficacy depends on its circulating half-life, which is influenced by hTfR binding valency and BBB transport.
bioRxiv · Nov 4, 2026 · PreprintBioengineering